Trial Profile
An Intravenous, Single Dose Safety, Tolerance and Pharmacokinetic Study of GE-145 in Healthy Volunteers Undergoing a Contrast-enhanced Abdominal Computed Tomography (CT) Scan
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Ioforminol (Primary) ; Iodixanol
- Indications Cardiovascular disorders
- Focus Diagnostic use
- Sponsors GE Healthcare
- 28 May 2014 New trial record